Division of Cardiothoracic Surgery, Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, Georgia.
Division of Cardiothoracic Surgery, Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, Georgia.
Ann Thorac Surg. 2024 Dec;118(6):1262-1270. doi: 10.1016/j.athoracsur.2024.07.021. Epub 2024 Aug 3.
The outcomes of single-ventricle palliation in unbalanced atrioventricular canal defect with coarctation of aorta (uAVC+CoA) have not been well studied. Systemic ventricle outflow tract obstruction has a propensity to develop in these patients after aortic arch repair with pulmonary artery banding (arch-PAB), which may adversely affect survival and Fontan candidacy.
A retrospective review was performed of patients who underwent single-ventricle palliation for uAVC+CoA from 2000 to 2022. Patients were divided into 2 groups based on initial palliation: (1) arch-PAB and (2) Norwood procedure. Demographic and clinical characteristics were analyzed and compared along with survival data.
Stage 1 palliation for uAVC+CoA was performed in 41 patients. Arch-PAB was performed in 14 infants and Norwood in 27 infants. Arch-PAB patients had more chromosomal abnormalities (28.6 vs 7.4%, P < .009) and less severe systemic ventricle outflow tract obstruction on baseline echocardiogram (0.0 vs 70.4%, P < .001). Survival to stage 3 palliation was lower for the arch-PAB group (28.6% vs 66.6%, P = .02). Arch-PAB remained a significant risk factor for mortality (hazard ratio, 2.93; 95% CI, 1.05-8.53; P = .04) after adjusting for chromosomal abnormalities and atrioventricular valve regurgitation. After arch-PAB, systemic ventricle outflow tract obstruction was diagnosed in 13 of 14 patients. Echocardiography underestimated the degree of outflow tract obstruction in 10 of 13 arch-PAB patients.
Arch-PAB has worse outcomes than Norwood for uAVC+CoA. Systemic ventricle outflow tract obstruction develops in almost all patients after arch-PAB. Outflow tract obstruction is underestimated by the echocardiogram and requires a high index of suspicion, along with advanced imaging, to ensure timely diagnosis and management.
主动脉缩窄(coarctation of aorta,CoA)合并房室通道不均衡(unbalanced atrioventricular canal defect,uAVC)患者行单心室姑息手术后的结局尚未得到很好的研究。这些患者在主动脉弓修复伴肺动脉带缩窄(arch-PAB)后,系统心室流出道梗阻有发展的倾向,这可能对生存和 Fontan 候选者产生不利影响。
回顾性分析了 2000 年至 2022 年期间因 uAVC+CoA 行单心室姑息治疗的患者。根据初始姑息治疗将患者分为两组:(1)arch-PAB 组;(2)Norwood 手术组。分析比较了两组患者的人口统计学和临床特征以及生存数据。
41 例患者行 uAVC+CoA 的一期姑息治疗。14 例患者行 arch-PAB,27 例患者行 Norwood 手术。arch-PAB 组患者的染色体异常发生率更高(28.6% vs 7.4%,P<.009),基线超声心动图上的系统心室流出道梗阻程度较轻(0.0% vs 70.4%,P<.001)。arch-PAB 组的 3 期姑息治疗生存率较低(28.6% vs 66.6%,P=.02)。调整染色体异常和房室瓣反流因素后,arch-PAB 仍然是死亡的显著危险因素(风险比 2.93;95%置信区间,1.05-8.53;P=.04)。arch-PAB 后,14 例患者中有 13 例诊断为系统心室流出道梗阻。arch-PAB 患者中有 10 例的超声心动图低估了流出道梗阻的程度。
arch-PAB 治疗 uAVC+CoA 的结局比 Norwood 差。arch-PAB 后几乎所有患者都会出现系统心室流出道梗阻。超声心动图低估了流出道梗阻的程度,需要高度怀疑,并结合高级影像学检查,以确保及时诊断和治疗。